HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bettina Bannert Selected Research

petesicatib

1/2019Differential effects of specific cathepsin S inhibition in biocompartments from patients with primary Sjögren syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bettina Bannert Research Topics

Disease

3Rheumatoid Arthritis
08/2022 - 01/2017
2Rheumatic Diseases (Rheumatism)
01/2019 - 01/2018
1Gout
01/2022
1Inflammation (Inflammations)
01/2022
1Arthritis (Polyarthritis)
01/2022
1Giant Cell Arteritis (Horton Disease)
01/2022
1Axial Spondyloarthritis
01/2019
1Back Pain (Backache)
01/2019
1Diphtheria
01/2019
1Human Influenza (Influenza)
01/2019
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2019
1Ankylosing Spondylitis
01/2019
1Tetanus
01/2019
1Systemic Scleroderma (Systemic Sclerosis)
03/2013
1Weight Loss (Weight Reduction)
01/2011

Drug/Important Bio-Agent (IBA)

2AutoantibodiesIBA
01/2019 - 03/2013
1Abatacept (Orencia)FDA Link
08/2022
1tocilizumab (atlizumab)FDA Link
01/2022
1ChemokinesIBA
01/2022
1Phosphotransferases (Kinase)IBA
01/2022
1Proteins (Proteins, Gene)FDA Link
01/2022
1Chemotactic FactorsIBA
01/2022
1Cysteine Proteases (Cysteine Protease)IBA
01/2019
1O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA
01/2019
1cathepsin SIBA
01/2019
1Rituximab (Mabthera)FDA Link
01/2019
1AntigensIBA
01/2019
1Bromodeoxyuridine (BrdU)IBA
01/2019
1Immunoglobulin A (IgA)IBA
01/2019
1Immunoglobulin G (IgG)IBA
01/2019
1Tetanus Toxoid (Vaccine, Tetanus)FDA Link
01/2019
1HLA-B27 Antigen (HLA B27 Antigen)IBA
01/2019
1Diphtheria-Tetanus VaccineIBA
01/2019
1petesicatibIBA
01/2019
1Retinaldehyde (Retinal)IBA
01/2018
1tofacitinibIBA
01/2017
1Janus Kinase InhibitorsIBA
01/2017
1AntibodiesIBA
03/2013

Therapy/Procedure

1Therapeutics
01/2011